Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	36.05	32.79	24.46	18.89	30.37	22.52
Short-Term Investments	13.05	24.15	33.75	106.08	26.95	75.56
Cash & Short-Term Investments	49.1	56.93	58.21	124.97	57.33	98.08
Cash Growth	-23.70%	-2.19%	-53.42%	117.99%	-41.55%	-23.70%
Receivables	28.9	30.55	40.32	15.47	15.97	10.11
Inventory	10.26	11.78	17.38	6.62	5.64	4.35
Prepaid Expenses	6.46	-	-	7.41	10.05	6.46
Total Current Assets	94.72	99.27	115.9	154.47	88.98	119.01
Property, Plant & Equipment	0.68	1.03	2.79	11.89	20.57	27.87
Other Intangible Assets	28.28	13.88	14.95	-	-	-
Other Long-Term Assets	4.74	3.06	0.64	0.97	0.82	0.7
Total Assets	128.41	117.23	134.28	167.33	110.38	147.57
Accounts Payable	6.13	7.14	22.51	3.8	3.71	4.15
Accrued Expenses	31.15	29.28	31.91	31.75	24.01	21.26
Current Portion of Long-Term Debt	-	10.87	3.94	7.97	-	-
Current Portion of Leases	0.64	0.69	1.13	9.89	8.62	7.27
Current Unearned Revenue	1.36	1.36	1.37	2.6	3.02	25.29
Other Current Liabilities	19.37	3.93	4.36	7.55	1.49	0.24
Total Current Liabilities	58.65	53.27	65.21	63.55	40.84	58.21
Long-Term Debt	99.67	92.32	81.71	72.64	19.82	9.81
Long-Term Leases	-	0.29	0.97	0.76	10.65	19.23
Long-Term Unearned Revenue	-	-	-	-	-	1.4
Other Long-Term Liabilities	-	-	-	-	5.05	5.1
Total Liabilities	158.32	145.87	147.9	136.95	76.35	93.75
Common Stock	0.02	0.18	0.17	0.17	0.17	0.17
Additional Paid-In Capital	1,387	1,379	1,369	1,354	1,340	1,330
Retained Earnings	-1,417	-1,408	-1,382	-1,324	-1,306	-1,276
Comprehensive Income & Other	-0.01	0.01	-0.15	-0.1	-0	0.02
Shareholders' Equity	-29.91	-28.64	-13.62	30.37	34.03	53.82
Total Liabilities & Equity	128.41	117.23	134.28	167.33	110.38	147.57
Total Debt	100.31	104.17	87.75	91.27	39.09	36.31
Net Cash (Debt)	-51.21	-47.23	-29.55	33.7	18.24	61.77
Net Cash Growth	-	-	-	84.77%	-70.47%	-51.95%
Net Cash Per Share	-2.93	-2.71	-1.71	1.98	1.08	3.69
Filing Date Shares Outstanding	17.59	17.54	17.37	17.17	17	16.86
Total Common Shares Outstanding	17.59	17.48	17.34	17.16	16.93	16.8
Working Capital	36.07	46	50.69	90.91	48.14	60.79
Book Value Per Share	-1.70	-1.64	-0.79	1.77	2.01	3.20
Tangible Book Value	-58.19	-42.52	-28.57	30.37	34.03	53.82
Tangible Book Value Per Share	-3.31	-2.43	-1.65	1.77	2.01	3.20
Machinery	-	1.83	9.48	16.04	15.53	14.64
Construction In Progress	-	-	-	0.69	0.82	0.56
Leasehold Improvements	-	-	2.11	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.